[Measurement of treatment efficacy in diabetes: effect of atherosclerosis prevention and general effects].

Numerous indirect and direct, long-term, well designate, multicenter studies are pointing to the fact, that intensification of the hypoglycemic therapy of diabetes mellitus and also the control of the non-hyperglycemic risk factors of atherosclerosis decrease the incidence, morbidity and mortality due to atherosclerosis complications in the subpopulation of diabetics type I as well as type II. This positive finding requires the objective monitoring of the quality of diabetes mellitus care. One has to be sure, that its activity exerts also the anti-atherogenic effect. The respective indices are presented using the suggestions of the experts committees of the European Association for the Study of Diabetes (EASD).